Cargando…
596 empresas que cubrimos, 361 de ellas calificadas
Todas las empresas de aquí pasadas por las mismas cinco comprobaciones sobre crecimiento y generación de caja. Describe la industria tal como se declara hoy, no cuál de estas comprar.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | 133,5B US$ | 526,82 US$ | 30,68 | 12,6B US$ | 35,0 % |
| MRNA | Moderna, Inc. | D- | 81,2B US$ | 203,44 US$ | — | 2,2B US$ | -141,4 % |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | 80,1B US$ | 750,43 US$ | 18,54 | 15,5B US$ | 27,9 % |
| LGVN | LONGEVERON INC. | F- | 76,2B US$ | 2,71 US$ | — | 1,2M US$ | -1977,6 % |
| ARGX | ARGENX SE | sin calificar | 60,1B US$ | 970,42 US$ | 49,59 | — | — |
| RVMD | Revolution Medicines, Inc. | F | 43,8B US$ | 204,57 US$ | — | 0,00 US$ | — |
| ONC | BEONE MEDICINES LTD. | A+ | 41,6B US$ | 365,49 US$ | 65,38 | 6,1B US$ | 10,7 % |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | A+ | 34B US$ | 254,04 US$ | 128,95 | 3,7B US$ | 19,7 % |
| RPRX | Royalty Pharma plc | B+ | 32,4B US$ | 58,22 US$ | 30,97 | 2,5B US$ | 32,1 % |
| NCNA | NUCANA PLC | sin calificar | 26,6B US$ | 1,28 US$ | — | — | — |
| ROIV | ROIVANT SCIENCES LTD. | F- | 26,4B US$ | 36,51 US$ | — | 7,5M US$ | -3535,0 % |
| INSM | INSMED INC | C- | 25,3B US$ | 115,65 US$ | — | 1,1B US$ | -76,9 % |
| BNTX | BioNTech SE | D | 24,8B US$ | 98,54 US$ | — | 3B US$ | -42,9 % |
| INCY | INCYTE CORPORATION | A+ | 24,6B US$ | 123,25 US$ | 17,41 | 5,4B US$ | 26,7 % |
| AKTX | Akari Therapeutics, Plc | sin calificar | 15,4B US$ | 9,86 US$ | — | — | — |
| JAZZ | Jazz Pharmaceuticals plc | A+ | 15,1B US$ | 232,46 US$ | 15,89 | 4,6B US$ | 20,4 % |
| EXEL | Exelixis Inc | A+ | 14,5B US$ | 58,66 US$ | 18,45 | 2,4B US$ | 35,3 % |
| ASND | Ascendis Pharma A/S | D | 14,1B US$ | 228,11 US$ | — | 1,2B US$ | -21,8 % |
| SMMT | Summit Therapeutics Inc. | F | 13,1B US$ | 16,37 US$ | — | 0,00 US$ | — |
| BBIO | BridgeBio Pharma, Inc. | B | 12,9B US$ | 65,94 US$ | — | 713,1M US$ | -98,5 % |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | 12,7B US$ | 111,54 US$ | 32,52 | 1,7B US$ | 24,9 % |
| CORT | CORCEPT THERAPEUTICS INC | C | 12,4B US$ | 114,79 US$ | 273,31 | 830,8M US$ | 6,6 % |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | C- | 11,8B US$ | 508,58 US$ | — | 1,3B US$ | -25,3 % |
| TWST | Twist Bioscience Corporation | C- | 11,7B US$ | 186,06 US$ | — | 431,8M US$ | -31,7 % |
| BMRN | BIOMARIN PHARMACEUTICAL INC | A | 11,6B US$ | 59,90 US$ | 161,89 | 3,4B US$ | 2,1 % |
| TECH | BIO-TECHNE Corp | B+ | 11,3B US$ | 72,37 US$ | 62,93 | 1,2B US$ | 15,0 % |
| KRYS | Krystal Biotech, Inc. | A+ | 9,9B US$ | 334,94 US$ | 41,97 | 440,5M US$ | 54,8 % |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | 9,7B US$ | 185,93 US$ | — | 776,6M US$ | -24,7 % |
| IBRX | IMMUNITYBIO, INC. | B | 9,4B US$ | 8,83 US$ | — | 165,8M US$ | -598,6 % |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | D- | 9,4B US$ | 66,21 US$ | — | 669,5M US$ | -47,8 % |
| KYMR | KYMERA THERAPEUTICS, INC. | D- | 9,2B US$ | 110,56 US$ | — | 105M US$ | -285,3 % |
| CYTK | CYTOKINETICS, INCORPORATED | F | 9,1B US$ | 65,67 US$ | — | 67,7M US$ | -1321,1 % |
| PTGX | Protagonist Therapeutics, Inc | A+ | 9,1B US$ | 140,93 US$ | 138,17 | 282M US$ | 29,4 % |
| CAI | CARIS LIFE SCIENCES, INC. | A+ | 8,9B US$ | 31,56 US$ | 18,67 | 989,6M US$ | 10,6 % |
| TGTX | TG THERAPEUTICS, INC. | A+ | 8,6B US$ | 56,19 US$ | 20,43 | 799,5M US$ | 55,2 % |
| PCVX | VAXCYTE, INC. | sin calificar | 8,4B US$ | 56,71 US$ | — | — | — |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | 7,9B US$ | 281,36 US$ | — | 0,00 US$ | — |
| ABVX | Abivax S.A. | sin calificar | 7,7B US$ | 98,50 US$ | — | — | — |
| IONS | Ionis Pharmaceuticals, Inc. | F- | 7,6B US$ | 45,91 US$ | — | 874,1M US$ | -64,7 % |
| SYRE | SPYRE THERAPEUTICS, INC. | F | 7,5B US$ | 84,70 US$ | — | 0,00 US$ | — |
| GPCR | Structure Therapeutics Inc. | sin calificar | 7B US$ | 32,66 US$ | — | — | — |
| IMVT | IMMUNOVANT, INC. | sin calificar | 6,9B US$ | 33,45 US$ | — | — | — |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | 6,6B US$ | 95,72 US$ | — | 239,9M US$ | -85,6 % |
| BLTE | Belite Bio, Inc | sin calificar | 6,5B US$ | 166,47 US$ | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | 6,5B US$ | 14,45 US$ | — | 325M US$ | -89,1 % |
| CGON | CG Oncology, Inc. | D- | 6,3B US$ | 70,56 US$ | — | 6,2M US$ | -3602,7 % |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | A+ | 6,2B US$ | 310,37 US$ | 32,98 | 290,5M US$ | 67,9 % |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F | 5,8B US$ | 47,73 US$ | — | 0,00 US$ | — |
| KOD | KODIAK SCIENCES INC. | sin calificar | 5,7B US$ | 91,15 US$ | — | — | — |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | 5,7B US$ | 87,58 US$ | — | 618,1M US$ | -139,2 % |
| GOSS | GOSSAMER BIO, INC. | B | 5,7B US$ | 11,61 US$ | — | 53,3M US$ | -235,0 % |
| TVTX | TRAVERE THERAPEUTICS, INC. | D- | 5,7B US$ | 60,01 US$ | — | 591,3M US$ | -7,4 % |
| COGT | Cogent Biosciences, Inc. | sin calificar | 5,5B US$ | 31,66 US$ | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | sin calificar | 5,4B US$ | 82,11 US$ | — | — | — |
| PTCT | PTC Therapeutics, Inc. | D | 5,4B US$ | 64,96 US$ | — | 1B US$ | -3,8 % |
| CRSP | CRISPR THERAPEUTICS AG | F- | 5,4B US$ | 56,03 US$ | — | 13,4M US$ | -3368,7 % |
| DFTX | Definium Therapeutics, Inc. | sin calificar | 5,1B US$ | 38,22 US$ | — | — | — |
| ERAS | Erasca, Inc. | sin calificar | 5B US$ | 14,22 US$ | — | — | — |
| MANE | Veradermics, Inc | sin calificar | 4,9B US$ | 117,80 US$ | — | — | — |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | F- | 4,9B US$ | 87,18 US$ | — | 2M US$ | -9442,3 % |
| ABCL | AbCellera Biologics Inc. | D- | 4,5B US$ | 14,83 US$ | — | 66,2M US$ | -248,8 % |
| EWTX | Edgewise Therapeutics, Inc. | sin calificar | 4,3B US$ | 39,19 US$ | — | — | — |
| TNGX | Tango Therapeutics, Inc. | F- | 4,1B US$ | 24,45 US$ | — | 53,8M US$ | -229,9 % |
| RLAY | Relay Therapeutics, Inc. | C- | 4B US$ | 18,38 US$ | — | 10,4M US$ | -2763,6 % |
| TLX | Telix Pharmaceuticals Limited | D- | 3,8B US$ | 11,34 US$ | — | 803,8M US$ | -0,9 % |
| CELC | CELCUITY INC. | sin calificar | 3,8B US$ | 77,30 US$ | — | — | — |
| VKTX | Viking Therapeutics, Inc. | F | 3,7B US$ | 31,81 US$ | — | 0,00 US$ | — |
| IDYA | IDEAYA Biosciences, Inc. | D- | 3,6B US$ | 37,82 US$ | — | 234,1M US$ | -74,8 % |
| XENE | XENON PHARMACEUTICALS INC. | F | 3,6B US$ | 37,27 US$ | — | 0,00 US$ | — |
| ACAD | ACADIA PHARMACEUTICALS INC. | A+ | 3,5B US$ | 20,22 US$ | 9,07 | 1,1B US$ | 33,4 % |
| LEGN | Legend Biotech Corp | C- | 3,5B US$ | 18,81 US$ | — | 1B US$ | -24,6 % |
| DBVT | DBV Technologies S.A. | F- | 3,4B US$ | 11,57 US$ | — | 5M US$ | -3506,5 % |
| ELVN | ENLIVEN THERAPEUTICS, INC. | sin calificar | 3,4B US$ | 46,51 US$ | — | — | — |
| TARS | TARSUS PHARMACEUTICALS, INC. | A | 3,4B US$ | 76,79 US$ | — | 606,3M US$ | -7,7 % |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | A | 3,4B US$ | 26,74 US$ | 127,33 | 464M US$ | 6,1 % |
| DNLI | Denali Therapeutics Inc. | F- | 3,3B US$ | 20,82 US$ | — | 3,6M US$ | -14.191,2 % |
| RCUS | Arcus Biosciences, Inc. | D- | 3,3B US$ | 25,64 US$ | — | 117M US$ | -393,2 % |
| DYN | Dyne Therapeutics, Inc. | sin calificar | 3B US$ | 16,22 US$ | — | — | — |
| PGEN | PRECIGEN, INC. | F- | 2,9B US$ | 8,06 US$ | — | 9,7M US$ | -1628,5 % |
| NAMS | NewAmsterdam Pharma Company N.V. | F- | 2,8B US$ | 23,82 US$ | — | 7,1M US$ | -3644,2 % |
| MBX | MBX Biosciences, Inc. | sin calificar | 2,8B US$ | 57,78 US$ | — | — | — |
| BEAM | Beam Therapeutics Inc. | C- | 2,5B US$ | 24,51 US$ | — | 156M US$ | -54,7 % |
| IRON | Disc Medicine, Inc. | sin calificar | 2,5B US$ | 65,89 US$ | — | — | — |
| IMNM | Immunome, Inc. | F | 2,5B US$ | 21,88 US$ | — | 0,00 US$ | — |
| CLDX | Celldex Therapeutics, Inc. | F- | 2,5B US$ | 31,62 US$ | — | 158K US$ | -190.220,9 % |
| NRIX | NURIX THERAPEUTICS, INC. | F- | 2,5B US$ | 23,69 US$ | — | 36,8M US$ | -928,4 % |
| VERA | Vera Therapeutics, Inc. | sin calificar | 2,3B US$ | 32,38 US$ | — | — | — |
| SLS | SELLAS Life Sciences Group, Inc. | sin calificar | 2,3B US$ | 11,51 US$ | — | — | — |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | A+ | 2,3B US$ | 39,28 US$ | 12,71 | 959,9M US$ | 18,9 % |
| VRDN | Viridian Therapeutics, Inc./DE | D- | 2,3B US$ | 20,00 US$ | — | 71,1M US$ | -544,1 % |
| ADMA | ADMA BIOLOGICS, INC. | A+ | 2,2B US$ | 9,97 US$ | 14,24 | 512,3M US$ | 33,0 % |
| GMAB | Genmab A/S | A+ | 2,2B US$ | 35,57 US$ | 2,31 | 3,7B US$ | 25,9 % |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | 2,2B US$ | 16,43 US$ | 7,17 | 311,5M US$ | 100,8 % |
| MLYS | MINERALYS THERAPEUTICS, INC. | sin calificar | 2,2B US$ | 24,44 US$ | — | — | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | 2,2B US$ | 4,03 US$ | — | 54,9M US$ | -945,9 % |
| VCEL | VERICEL CORPORATION | A | 2,1B US$ | 40,63 US$ | 86,44 | 306,3M US$ | 7,9 % |
| PHVS | Pharvaris N.V. | sin calificar | 2,1B US$ | 31,71 US$ | — | — | — |
| TRVI | Trevi Therapeutics, Inc. | sin calificar | 2,1B US$ | 14,42 US$ | — | — | — |
| NKTR | Nektar Therapeutics | F- | 2B US$ | 59,31 US$ | — | 54,6M US$ | -287,8 % |
| BHVN | Biohaven Ltd. | sin calificar | 2B US$ | 13,30 US$ | — | — | — |
| PVLA | Palvella Therapeutics, Inc. | sin calificar | 2B US$ | 139,07 US$ | — | — | — |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | 2B US$ | 33,30 US$ | — | 98,3M US$ | -418,2 % |
| GENB | Generate Biomedicines, Inc. | sin calificar | 2B US$ | 15,42 US$ | — | — | — |
| URGN | UroGen Pharma Ltd. | C | 2B US$ | 40,44 US$ | — | 188,7M US$ | -51,7 % |
| NUVB | Nuvation Bio Inc. | C- | 2B US$ | 5,62 US$ | — | 169,9M US$ | -88,2 % |
| SRPT | SAREPTA THERAPEUTICS, INC. | B- | 2B US$ | 18,65 US$ | — | 2B US$ | -6,9 % |
| LKFT | GALAPAGOS NV | B | 1,9B US$ | 29,56 US$ | 5,34 | 1,3B US$ | 28,9 % |
| MESO | MESOBLAST LIMITED | C- | 1,9B US$ | 14,89 US$ | — | 65,4M US$ | -156,2 % |
| ZYME | ZYMEWORKS INC. | F- | 1,9B US$ | 27,14 US$ | — | 37,1M US$ | -404,0 % |
| FTRE | FORTREA HOLDINGS INC. | C | 1,9B US$ | 19,76 US$ | — | 2,7B US$ | -3,2 % |
| XNCR | Xencor, Inc | F- | 1,9B US$ | 24,99 US$ | — | 105M US$ | -155,6 % |
| SEPN | Septerna, Inc. | B | 1,8B US$ | 39,11 US$ | — | 98,9M US$ | -24,5 % |
| VIR | Vir Biotechnology, Inc. | C- | 1,8B US$ | 10,66 US$ | — | 303,2M US$ | -83,0 % |
| NVAX | NOVAVAX INC | D | 1,8B US$ | 10,83 US$ | — | 413,8M US$ | -59,9 % |
| ZBIO | Zenas BioPharma, Inc. | F- | 1,7B US$ | 26,74 US$ | — | 10M US$ | -4843,8 % |
| ABSI | ABSCI CORP | F- | 1,7B US$ | 10,13 US$ | — | 1,6M US$ | -7756,4 % |
| OCUL | OCULAR THERAPEUTIX, INC | F- | 1,7B US$ | 7,86 US$ | — | 52,1M US$ | -579,1 % |
| NTLA | INTELLIA THERAPEUTICS, INC. | C- | 1,7B US$ | 12,04 US$ | — | 59,5M US$ | -672,2 % |
| STOK | Stoke Therapeutics, Inc. | F- | 1,7B US$ | 25,90 US$ | — | 27,6M US$ | -753,6 % |
| TSHA | Taysha Gene Therapies, Inc. | F- | 1,6B US$ | 5,00 US$ | — | 5,5M US$ | -2728,0 % |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | 1,6B US$ | 18,24 US$ | — | 252,3M US$ | -87,5 % |
| RAPP | Rapport Therapeutics, Inc. | sin calificar | 1,6B US$ | 33,07 US$ | — | — | — |
| IMCR | Immunocore Holdings plc | C- | 1,6B US$ | 30,76 US$ | — | 430,8M US$ | -4,2 % |
| QURE | uniQure N.V. | C- | 1,5B US$ | 24,51 US$ | — | 18,1M US$ | -1154,4 % |
| INBX | INHIBRX BIOSCIENCES, INC. | D- | 1,5B US$ | 104,83 US$ | — | 1,3M US$ | -10.629,3 % |
| GHRS | GH Research PLC | sin calificar | 1,5B US$ | 24,70 US$ | — | — | — |
| NBTX | Nanobiotix S.A. | C- | 1,5B US$ | 31,59 US$ | — | 37,1M US$ | -73,5 % |
| INVA | INNOVIVA, INC. | B+ | 1,5B US$ | 21,12 US$ | 5,14 | 440M US$ | 81,2 % |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | 1,5B US$ | 15,32 US$ | — | 717,2M US$ | -81,7 % |
| ANAB | ANAPTYSBIO, INC. | B+ | 1,5B US$ | 50,32 US$ | 8,77 | 237,6M US$ | 82,4 % |
| MAZE | MAZE THERAPEUTICS, INC. | F- | 1,5B US$ | 27,02 US$ | — | 167,5M US$ | -79,8 % |
| AVBP | ARRIVENT BIOPHARMA, INC. | sin calificar | 1,5B US$ | 29,54 US$ | — | — | — |
| OMER | OMEROS CORP | sin calificar | 1,4B US$ | 19,27 US$ | 11,20 | — | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | F- | 1,4B US$ | 14,86 US$ | — | 85,6M US$ | -216,5 % |
| ORIC | ORIC PHARMACEUTICALS, INC. | sin calificar | 1,4B US$ | 13,35 US$ | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | sin calificar | 1,3B US$ | 15,20 US$ | — | — | — |
| TYRA | Tyra Biosciences, Inc. | sin calificar | 1,3B US$ | 21,98 US$ | — | — | — |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | sin calificar | 1,3B US$ | 35,97 US$ | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | sin calificar | 1,3B US$ | 20,65 US$ | — | — | — |
| BCAX | Bicara Therapeutics Inc. | sin calificar | 1,2B US$ | 18,54 US$ | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | sin calificar | 1,2B US$ | 12,99 US$ | — | — | — |
| LBRX | LB Pharmaceuticals Inc | sin calificar | 1,2B US$ | 37,23 US$ | — | — | — |
| IMTX | Immatics N.V. | sin calificar | 1,1B US$ | 8,56 US$ | — | — | — |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | 1,1B US$ | 7,65 US$ | — | 208,8M US$ | -37,1 % |
| VOR | Vor Biopharma Inc. | sin calificar | 1,1B US$ | 18,33 US$ | 0,10 | — | — |
| MNKD | MANNKIND CORP | C | 1,1B US$ | 3,34 US$ | — | 393,6M US$ | -11,1 % |
| MGTX | MeiraGTx Holdings plc | A | 1,1B US$ | 11,13 US$ | 15,67 | 397,5M US$ | 19,9 % |
| SVRA | Savara Inc | sin calificar | 1B US$ | 5,10 US$ | — | — | — |
| ANRO | Alto Neuroscience, Inc. | sin calificar | 1B US$ | 26,58 US$ | — | — | — |
| JANX | Janux Therapeutics, Inc. | B- | 1B US$ | 16,95 US$ | — | 24M US$ | -427,5 % |
| AKTS | Aktis Oncology, Inc. | sin calificar | 1B US$ | 19,72 US$ | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | 1B US$ | 14,50 US$ | — | 92M US$ | -194,7 % |
| GLUE | Monte Rosa Therapeutics, Inc. | D- | 1B US$ | 11,75 US$ | — | 28,7M US$ | -560,8 % |
| APMD | Apnimed, Inc. | sin calificar | 996,6M US$ | 23,94 US$ | — | — | — |
| CRVS | Corvus Pharmaceuticals, Inc. | sin calificar | 986,7M US$ | 11,73 US$ | — | — | — |
| CGEM | CULLINAN THERAPEUTICS, INC. | sin calificar | 980,8M US$ | 15,24 US$ | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | sin calificar | 973,6M US$ | 11,44 US$ | — | — | — |
| KURA | KURA ONCOLOGY, INC. | D- | 960,8M US$ | 10,80 US$ | — | 77,2M US$ | -384,3 % |
| ABUS | Arbutus Biopharma Corp | C+ | 926,9M US$ | 4,69 US$ | 5,93 | 181,7M US$ | 84,2 % |
| ALMS | Alumis Inc. | D- | 920M US$ | 7,28 US$ | — | 7,4M US$ | -5933,5 % |
| RIGL | RIGEL PHARMACEUTICALS, INC. | B+ | 913,1M US$ | 48,88 US$ | 2,90 | 276,8M US$ | 116,3 % |
| JAGX | JAGUAR HEALTH, INC. | B | 906,4M US$ | 5,29 US$ | — | 27,8M US$ | -132,2 % |
| JBIO | Jade Biosciences, Inc. | sin calificar | 903,1M US$ | 14,20 US$ | — | — | — |
| TBPH | Theravance Biopharma, Inc. | B | 884,2M US$ | 17,03 US$ | 16,86 | 104,3M US$ | 51,6 % |
| SANA | Sana Biotechnology, Inc. | sin calificar | 874,1M US$ | 2,92 US$ | — | — | — |
| SGP | SpyGlass Pharma, Inc. | sin calificar | 851,3M US$ | 25,45 US$ | — | — | — |
| ARDX | ARDELYX, INC. | B- | 843,5M US$ | 3,39 US$ | — | 450,9M US$ | -12,4 % |
| LXRX | LEXICON PHARMACEUTICALS, INC. | C- | 838,7M US$ | 1,89 US$ | — | 41,5M US$ | -147,4 % |
| AVTX | AVALO THERAPEUTICS, INC. | F- | 834,2M US$ | 15,56 US$ | — | 59K US$ | -170.055,9 % |
| CADL | CANDEL THERAPEUTICS, INC. | sin calificar | 832,5M US$ | 10,88 US$ | — | — | — |
| ANNX | ANNEXON, INC. | sin calificar | 819,1M US$ | 4,15 US$ | — | — | — |
| GYRE | Gyre Therapeutics, Inc. | D- | 817,4M US$ | 7,33 US$ | — | 119,4M US$ | -23,6 % |
| GERN | GERON CORP | sin calificar | 796,7M US$ | 1,24 US$ | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | sin calificar | 791,8M US$ | 7,70 US$ | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | 791M US$ | 12,64 US$ | — | 0,00 US$ | — |
| ACRS | Aclaris Therapeutics, Inc. | D- | 777,2M US$ | 5,28 US$ | — | 8,2M US$ | -921,5 % |
| SLDB | Solid Biosciences Inc. | sin calificar | 768,8M US$ | 7,17 US$ | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | sin calificar | 752,6M US$ | 10,52 US$ | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | sin calificar | 748,1M US$ | 8,55 US$ | — | — | — |
| VSTM | Verastem, Inc. | D- | 716,4M US$ | 7,91 US$ | — | 87,5M US$ | -231,6 % |
| WVE | WAVE LIFE SCIENCES LTD. | F- | 715,3M US$ | 3,63 US$ | — | 42,7M US$ | -473,9 % |
| PHAR | Pharming Group N.V. | A | 714M US$ | 10,18 US$ | 254,38 | 376,1M US$ | 0,8 % |
| OABI | OMNIAB, INC. | D- | 689,2M US$ | 4,74 US$ | — | 38,5M US$ | -115,1 % |
| IMMP | Immutep Limited | D- | 683,5M US$ | 4,68 US$ | — | 7,3M US$ | -594,6 % |
| MDXG | MiMedx Group, Inc. | C | 680,7M US$ | 4,67 US$ | 116,75 | 355,2M US$ | 1,8 % |
| ZVRA | Zevra Therapeutics, Inc. | A+ | 672,8M US$ | 11,33 US$ | 12,32 | 136,1M US$ | 42,8 % |
| NVCT | Nuvectis Pharma, Inc. | sin calificar | 669,9M US$ | 20,56 US$ | — | — | — |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | D- | 663,8M US$ | 11,97 US$ | — | 111,9M US$ | -260,0 % |
| CLYM | CLIMB BIO, INC. | sin calificar | 661,7M US$ | 11,52 US$ | — | — | — |
| STTK | Shattuck Labs, Inc. | C- | 656,4M US$ | 6,54 US$ | — | 1M US$ | -5256,8 % |
| AURA | Aura Biosciences, Inc. | sin calificar | 638,3M US$ | 6,16 US$ | — | — | — |
| IVA | Inventiva S.A. | F | 636,7M US$ | 3,30 US$ | — | 5,1M US$ | -7899,6 % |
| CRMD | CORMEDIX INC. | A+ | 618,9M US$ | 7,94 US$ | 3,87 | 462,2M US$ | 40,5 % |
| IBO | Impact BioMedical, INC. | A | 600M US$ | 5,57 US$ | 6,32 | 35K US$ | 2254,3 % |
| CTMX | CytomX Therapeutics, Inc. | F- | 597M US$ | 2,74 US$ | — | 18,3M US$ | -435,2 % |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | 596,6M US$ | 7,38 US$ | — | 239,7M US$ | -41,3 % |
| ALT | ALTIMMUNE, INC. | D- | 575,8M US$ | 2,96 US$ | — | 41K US$ | -223.804,9 % |
| NGNE | Neurogene Inc. | F | 568,3M US$ | 28,40 US$ | — | 0,00 US$ | — |
| PRME | Prime Medicine, Inc. | C- | 564,1M US$ | 3,11 US$ | — | 4,6M US$ | -4056,4 % |
| ALLO | Allogene Therapeutics, Inc. | B- | 558M US$ | 1,62 US$ | — | 6,8M US$ | -2419,5 % |
| CBIO | CRESCENT BIOPHARMA, INC. | D- | 548,6M US$ | 14,77 US$ | — | 10,8M US$ | -885,5 % |
| YDES | YD Bio Limited | D | 547,9M US$ | 7,74 US$ | — | 596,8K US$ | -1392,6 % |
| MNPR | Monopar Therapeutics Inc. | F | 537,1M US$ | 80,02 US$ | — | 0,00 US$ | — |
| VALN | Valneva SE | D- | 534,9M US$ | 6,17 US$ | — | 177,9M US$ | -73,7 % |
| COAG | Hemab Therapeutics Holdings, Inc. | sin calificar | 509,9M US$ | 32,67 US$ | — | — | — |
| SLN | Silence Therapeutics plc | C- | 509,3M US$ | 10,78 US$ | — | 615K US$ | -9748,5 % |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | sin calificar | 507,4M US$ | 2,39 US$ | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | 505,4M US$ | 9,79 US$ | 18,83 | 231,2M US$ | 11,6 % |
| ANL | Adlai Nortye Ltd. | C | 502,2M US$ | 15,71 US$ | — | 5M US$ | -710,6 % |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | 498,3M US$ | 8,57 US$ | — | 0,00 US$ | — |
| PBLS | Parabilis Medicines, Inc. | sin calificar | 496M US$ | 31,89 US$ | — | — | — |
| AUTL | Autolus Therapeutics plc | C- | 492,4M US$ | 1,85 US$ | — | 117,4M US$ | -238,7 % |
| RGNX | REGENXBIO Inc. | D- | 490,8M US$ | 7,44 US$ | — | 174,5M US$ | -112,6 % |
| ARVN | ARVINAS, INC. | B | 490,7M US$ | 7,51 US$ | 31,27 | 316,7M US$ | 2,9 % |
| OCS | Oculis Holding AG | sin calificar | 477,5M US$ | 9,14 US$ | — | — | — |
| ASMB | Assembly Biosciences, Inc. | B- | 477,5M US$ | 23,45 US$ | 22,99 | 72,3M US$ | -0,1 % |
| TECX | TECTONIC THERAPEUTIC, INC. | sin calificar | 455,1M US$ | 23,28 US$ | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | C- | 451M US$ | 8,79 US$ | — | 54,5M US$ | -80,7 % |
| AGEN | AGENUS INC | C | 444,8M US$ | 9,88 US$ | 3,83 | 132,7M US$ | 69,3 % |
| DMAC | DiaMedica Therapeutics Inc. | sin calificar | 443,3M US$ | 8,22 US$ | — | — | — |
| SPRY | ARS Pharmaceuticals, Inc. | D- | 438,6M US$ | 4,41 US$ | — | 116,9M US$ | -184,2 % |
| MPLT | MapLight Therapeutics, Inc. | sin calificar | 429,5M US$ | 10,12 US$ | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | sin calificar | 429M US$ | 7,92 US$ | — | — | — |
| KYTX | Kyverna Therapeutics, Inc. | sin calificar | 423,6M US$ | 6,85 US$ | — | — | — |
| AVLN | Avalyn Pharma Inc. | sin calificar | 422M US$ | 27,19 US$ | — | — | — |
| AVIR | Atea Pharmaceuticals, Inc. | sin calificar | 413,9M US$ | 5,16 US$ | — | — | — |
| IRD | Opus Genetics, Inc. | F- | 411M US$ | 4,94 US$ | — | 9,9M US$ | -1091,8 % |
| ODTX | Odyssey Therapeutics, Inc. | sin calificar | 405,4M US$ | 22,48 US$ | — | — | — |
| TTRX | Turn Therapeutics Inc. | sin calificar | 402,7M US$ | 13,52 US$ | — | — | — |
| SGMT | Sagimet Biosciences Inc. | sin calificar | 399,8M US$ | 9,32 US$ | — | — | — |
| EDIT | EDITAS MEDICINE, INC. | B- | 398,5M US$ | 2,60 US$ | — | 47M US$ | -157,3 % |
| RLMD | RELMADA THERAPEUTICS, INC. | sin calificar | 397,9M US$ | 3,73 US$ | — | — | — |
| RZLT | REZOLUTE, INC. | sin calificar | 395,6M US$ | 4,09 US$ | — | — | — |
| GALT | GALECTIN THERAPEUTICS INC. | sin calificar | 394,3M US$ | 3,91 US$ | — | — | — |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | 389,1M US$ | 13,69 US$ | — | 29,4M US$ | -317,6 % |
| CCCC | C4 Therapeutics, Inc. | C- | 383,8M US$ | 3,12 US$ | — | 35M US$ | -289,4 % |
| ZURA | ZURA BIO LIMITED | sin calificar | 383,3M US$ | 4,00 US$ | — | — | — |
| FENC | FENNEC PHARMACEUTICALS INC. | C- | 378M US$ | 10,78 US$ | — | 59,2M US$ | -5,5 % |
| SRZN | Surrozen, Inc./DE | D | 374,6M US$ | 31,87 US$ | — | 11,5M US$ | -2885,3 % |
| OCGN | OCUGEN, INC. | C | 369,6M US$ | 1,09 US$ | — | 4,6M US$ | -1786,3 % |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | 368,7M US$ | 12,66 US$ | — | 65,3M US$ | -96,9 % |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | 365,7M US$ | 6,09 US$ | — | 32M US$ | -184,6 % |
| SPTX | Seaport Therapeutics, Inc. | sin calificar | 358,8M US$ | 18,77 US$ | — | — | — |
| ARTV | Artiva Biotherapeutics, Inc. | F- | 344,4M US$ | 7,05 US$ | — | 0,00 US$ | — |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | sin calificar | 341,6M US$ | 49,67 US$ | — | — | — |
| BNTC | Benitec Biopharma Inc. | D | 340,5M US$ | 9,76 US$ | — | 0,00 US$ | — |
| CABA | CABALETTA BIO, INC. | sin calificar | 336,5M US$ | 1,99 US$ | — | — | — |
| LRMR | LARIMAR THERAPEUTICS, INC. | sin calificar | 326,2M US$ | 3,14 US$ | — | — | — |
| IMUX | Immunic, Inc. | sin calificar | 325,1M US$ | 8,94 US$ | — | — | — |
| VERU | VERU INC. | sin calificar | 318,3M US$ | 2,58 US$ | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | 315,2M US$ | 3,95 US$ | — | 22,4M US$ | -269,7 % |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | sin calificar | 314,3M US$ | 3,92 US$ | — | — | — |
| GTBP | GT BIOPHARMA, INC. | sin calificar | 306,7M US$ | 6,80 US$ | 18,37 | — | — |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | 303,5M US$ | 5,02 US$ | — | 215,7M US$ | -127,4 % |
| EVMN | Evommune, Inc. | D- | 302,3M US$ | 8,33 US$ | — | 10M US$ | -946,7 % |
| IPSC | Century Therapeutics, Inc. | B- | 298,8M US$ | 1,65 US$ | — | 109,2M US$ | -100,6 % |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | 295,8M US$ | 8,30 US$ | — | 0,00 US$ | — |
| EYPT | EyePoint, Inc. | F- | 295,7M US$ | 3,43 US$ | — | 2,8M US$ | -10.994,7 % |
| ABEO | ABEONA THERAPEUTICS INC. | C- | 295,1M US$ | 5,16 US$ | — | 25,5M US$ | -246,4 % |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | 293,9M US$ | 3,23 US$ | — | 0,00 US$ | — |
| KARD | Kardigan, Inc. | sin calificar | 292,4M US$ | 14,70 US$ | — | — | — |
| XFOR | X4 PHARMACEUTICALS, INC | D- | 288,5M US$ | 2,91 US$ | — | 15,8M US$ | -568,8 % |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | 287,1M US$ | 14,54 US$ | — | 0,00 US$ | — |
| FATE | FATE THERAPEUTICS INC | D- | 285,2M US$ | 2,38 US$ | — | 6,5M US$ | -1941,1 % |
| UPB | UPSTREAM BIO, INC. | D- | 284,8M US$ | 5,20 US$ | — | 3,2M US$ | -4955,7 % |
| RCKT | Rocket Pharmaceuticals, Inc. | D | 284,3M US$ | 2,59 US$ | — | 0,00 US$ | — |
| QTTB | Q32 Bio Inc. | B | 284M US$ | 9,54 US$ | 3,05 | 53,7M US$ | 62,9 % |
| IKT | Inhibikase Therapeutics, Inc. | F | 282,6M US$ | 2,03 US$ | — | 0,00 US$ | — |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | 282,3M US$ | 3,70 US$ | — | 0,00 US$ | — |
| LXEO | Lexeo Therapeutics, Inc. | sin calificar | 280,6M US$ | 3,42 US$ | — | — | — |
| HELP | CYBIN INC. | sin calificar | 274,1M US$ | 12,69 US$ | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | sin calificar | 271,3M US$ | 18,48 US$ | — | — | — |
| IMRX | Immuneering Corporation | sin calificar | 267,8M US$ | 4,14 US$ | — | — | — |
| STRO | SUTRO BIOPHARMA, INC. | F | 267,5M US$ | 16,13 US$ | — | 45,7M US$ | -395,2 % |
| LIMN | LIMINATUS PHARMA, INC. | sin calificar | 263,6M US$ | 3,93 US$ | — | — | — |
| ACIU | AC IMMUNE SA | F- | 263,5M US$ | 2,59 US$ | — | 4,3M US$ | -1207,8 % |
| BCYC | Bicycle Therapeutics plc | D- | 255,3M US$ | 3,66 US$ | — | 61,2M US$ | -311,1 % |
| PALI | PALISADE BIO, INC. | C- | 251,8M US$ | 1,45 US$ | — | 500K US$ | -6388,2 % |
| IVVD | INVIVYD, INC. | C- | 250,6M US$ | 0,85 US$ | — | 58,4M US$ | -183,9 % |
| CTNM | Contineum Therapeutics, Inc. | D | 250,4M US$ | 10,84 US$ | — | 0,00 US$ | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | 245,4M US$ | 3,91 US$ | — | 3,5M US$ | -3065,9 % |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | 244,1M US$ | 6,27 US$ | — | 4,7M US$ | -3537,7 % |
| LCTX | Lineage Cell Therapeutics, Inc. | D- | 242,7M US$ | 0,96 US$ | — | 13,1M US$ | -246,6 % |
| PYXS | Pyxis Oncology, Inc. | D- | 241,5M US$ | 2,90 US$ | — | 13,9M US$ | -640,3 % |
| MGNX | MACROGENICS, INC. | C- | 239,5M US$ | 3,76 US$ | — | 167,7M US$ | -8,7 % |
| LYEL | Lyell Immunopharma, Inc. | D- | 236M US$ | 9,63 US$ | — | 27K US$ | -920.285,2 % |
| SION | SIONNA THERAPEUTICS, INC. | sin calificar | 232,8M US$ | 5,15 US$ | — | — | — |
| ZLAB | ZAI LAB LIMITED | C- | 229,6M US$ | 25,92 US$ | — | 449,6M US$ | -41,9 % |
| KROS | Keros Therapeutics, Inc. | D- | 222,5M US$ | 11,22 US$ | — | 15M US$ | -553,9 % |
| CGEN | COMPUGEN LTD | B+ | 221,3M US$ | 2,34 US$ | 6,16 | 74M US$ | 47,6 % |
| AVXL | ANAVEX LIFE SCIENCES CORP. | sin calificar | 220,6M US$ | 2,38 US$ | — | — | — |
| RNAC | Cartesian Therapeutics, Inc. | F | 219M US$ | 7,24 US$ | — | 1,5M US$ | -10.283,8 % |
| PLX | Protalix BioTherapeutics, Inc. | A+ | 217,5M US$ | 2,70 US$ | 11,74 | 80,6M US$ | 23,5 % |
| MLEC | MOOLEC SCIENCE SA | D | 217,4M US$ | 5,60 US$ | — | 333,6M US$ | -52,9 % |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | 213,2M US$ | 3,74 US$ | — | 0,00 US$ | — |
| ALEC | Alector, Inc. | D- | 209,9M US$ | 1,88 US$ | — | 13,9M US$ | -850,1 % |
| FHTX | Foghorn Therapeutics Inc. | B | 208,4M US$ | 3,51 US$ | — | 36,7M US$ | -175,8 % |
| ELDN | Eledon Pharmaceuticals, Inc. | sin calificar | 204,4M US$ | 2,52 US$ | — | — | — |
| SLGL | Sol-Gel Technologies Ltd. | B | 200,8M US$ | 72,08 US$ | — | 1,8M US$ | -341,3 % |
| CMPX | COMPASS THERAPEUTICS, INC. | F | 196,3M US$ | 1,09 US$ | — | 0,00 US$ | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | 195,1M US$ | 4,69 US$ | 1,14 | 2M US$ | 8743,5 % |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | 194,2M US$ | 2,71 US$ | — | 0,00 US$ | — |
| ANTX | AN2 Therapeutics, Inc. | sin calificar | 192,5M US$ | 5,10 US$ | — | — | — |
| TARA | Protara Therapeutics, Inc. | sin calificar | 190,6M US$ | 3,23 US$ | — | — | — |
| ADAG | Adagene Inc. | C- | 189,8M US$ | 3,21 US$ | — | 7,7M US$ | -229,6 % |
| ACOG | Alpha Cognition Inc. | D- | 189,5M US$ | 8,70 US$ | — | 15,3M US$ | -153,6 % |
| NKTX | Nkarta, Inc. | D | 188,4M US$ | 2,63 US$ | — | 0,00 US$ | — |
| CUE | Cue Biopharma, Inc. | D- | 186,3M US$ | 25,64 US$ | — | 37,7M US$ | -435,8 % |
| ALXO | ALX ONCOLOGY HOLDINGS INC | sin calificar | 185,3M US$ | 1,34 US$ | — | — | — |
| INDP | Indaptus Therapeutics, Inc. | sin calificar | 183,4M US$ | 2,86 US$ | — | — | — |
| CHRS | Coherus Oncology, Inc. | B | 183,1M US$ | 1,19 US$ | — | 50,9M US$ | -259,4 % |
| OVID | Ovid Therapeutics Inc. | C- | 180M US$ | 2,54 US$ | — | 1,6M US$ | -2178,9 % |
| MDWD | MEDIWOUND LTD. | F- | 177M US$ | 13,79 US$ | — | 11,9M US$ | -170,1 % |
| PRQR | ProQR Therapeutics N.V. | C- | 174,4M US$ | 1,66 US$ | — | 20,9M US$ | -229,7 % |
| MOLN | MOLECULAR PARTNERS AG | F- | 173,6M US$ | 4,30 US$ | — | 5,2M US$ | -1437,4 % |
| NAUT | Nautilus Biotechnology, Inc. | sin calificar | 173,1M US$ | 1,36 US$ | — | — | — |
| DTIL | PRECISION BIOSCIENCES INC | D- | 170,9M US$ | 6,19 US$ | — | 45,1M US$ | -117,0 % |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | 165,9M US$ | 9,67 US$ | — | 29,1M US$ | -548,6 % |
| VYGR | Voyager Therapeutics, Inc. | F- | 162,7M US$ | 2,64 US$ | — | 34,5M US$ | -312,6 % |
| PEPG | PEPGEN INC. | sin calificar | 162,1M US$ | 2,34 US$ | — | — | — |
| ABOS | Acumen Pharmaceuticals, Inc. | sin calificar | 162M US$ | 2,24 US$ | — | — | — |
| NERV | Minerva Neurosciences, Inc. | F | 160,4M US$ | 3,36 US$ | — | 0,00 US$ | — |
| KRSA | CYCLERION THERAPEUTICS, INC. | F- | 159,6M US$ | 34,10 US$ | — | 1,9M US$ | -353,0 % |
| BRVE | Braveheart Bio, Inc. | sin calificar | 159,6M US$ | 22,38 US$ | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | sin calificar | 158,7M US$ | 5,06 US$ | — | — | — |
| NBP | NovaBridge Biosciences | sin calificar | 158,6M US$ | 1,38 US$ | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | sin calificar | 154,3M US$ | 4,74 US$ | — | — | — |
| MENS | Jyong Biotech Ltd. | sin calificar | 153,6M US$ | 2,02 US$ | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | sin calificar | 153,3M US$ | 1,93 US$ | — | — | — |
| IPHA | Innate Pharma SA | F- | 150,9M US$ | 1,61 US$ | — | 10,2M US$ | -546,1 % |
| CDXS | Codexis, Inc. | D- | 148,4M US$ | 1,36 US$ | — | 77,7M US$ | -39,6 % |
| HUMA | Humacyte, Inc. | C- | 148,3M US$ | 0,53 US$ | — | 2,1M US$ | -4560,8 % |
| CLLS | Cellectis S.A. | C- | 147,4M US$ | 1,47 US$ | — | 72,9M US$ | -92,7 % |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | 144,5M US$ | 0,80 US$ | — | 4,9M US$ | -618,0 % |
| RNA | Atrium Therapeutics, Inc. | sin calificar | 144M US$ | 8,42 US$ | — | — | — |
| KRRO | Korro Bio, Inc. | C- | 141,1M US$ | 9,58 US$ | — | 2,4M US$ | -4477,1 % |
| SPRB | Spruce Biosciences, Inc. | F | 136,6M US$ | 47,53 US$ | — | 0,00 US$ | — |
| TNYA | Tenaya Therapeutics, Inc. | sin calificar | 134,6M US$ | 0,60 US$ | — | — | — |
| IFRX | InflaRx N.V. | F- | 134,5M US$ | 1,86 US$ | — | 33,4K US$ | -155.582,1 % |
| CRBU | Caribou Biosciences, Inc. | D- | 133,5M US$ | 1,25 US$ | — | 10M US$ | -1030,4 % |
| MSLE | Satellos Bioscience Inc. | sin calificar | 132,9M US$ | 8,60 US$ | — | — | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | sin calificar | 132,7M US$ | 3,57 US$ | — | — | — |
| VOGX | Vogenx, Inc. | sin calificar | 132,6M US$ | 24,32 US$ | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | 131,6M US$ | 2,07 US$ | — | 0,00 US$ | — |
| ENTX | ENTERA BIO LTD. | F | 131,6M US$ | 2,68 US$ | — | 0,00 US$ | — |
| ENGN | enGene Therapeutics Inc. | sin calificar | 130,7M US$ | 1,95 US$ | — | — | — |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | sin calificar | 127,7M US$ | 6,60 US$ | — | — | — |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | sin calificar | 127,3M US$ | 4,57 US$ | — | — | — |
| NMRA | NEUMORA THERAPEUTICS, INC. | sin calificar | 127,3M US$ | 0,68 US$ | — | — | — |
| LENZ | LENZ THERAPEUTICS, INC. | D- | 121,6M US$ | 3,87 US$ | — | 19,1M US$ | -660,1 % |
| SEER | SEER, INC. | D- | 119M US$ | 2,15 US$ | — | 14,2M US$ | -478,0 % |
| COYA | Coya Therapeutics, Inc. | F- | 118,3M US$ | 5,05 US$ | — | 8M US$ | -270,2 % |
| AARD | AARDVARK THERAPEUTICS, INC. | F | 118M US$ | 5,39 US$ | — | 0,00 US$ | — |
| INO | INOVIO PHARMACEUTICALS, INC. | D | 115,8M US$ | 1,12 US$ | — | 0,00 US$ | — |
| TLSA | Tiziana Life Sciences Ltd | sin calificar | 115,7M US$ | 0,96 US$ | — | — | — |
| VANI | Vivani Medical, Inc. | F | 111,9M US$ | 1,24 US$ | — | 0,00 US$ | — |
| GNLX | GENELUX CORPORATION | F- | 110,9M US$ | 2,45 US$ | — | 8K US$ | -444.950,0 % |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | D | 108M US$ | 1,88 US$ | — | 0,00 US$ | — |
| CNXU | CONEXEU SCIENCES INC. | sin calificar | 105,4M US$ | 3,74 US$ | — | — | — |
| OKUR | ONKURE THERAPEUTICS, INC. | C | 105,1M US$ | 2,60 US$ | — | 0,00 US$ | — |
| QNCX | Quince Therapeutics, Inc. | sin calificar | 104,3M US$ | 31,64 US$ | — | — | — |
| PLYX | Polaryx Therapeutics, Inc. | sin calificar | 102,7M US$ | 2,06 US$ | — | — | — |
| EQ | EQUILLIUM, INC. | C- | 102,4M US$ | 1,62 US$ | — | 41,1M US$ | -43,8 % |
| MIST | Milestone Pharmaceuticals Inc. | sin calificar | 101,2M US$ | 0,81 US$ | — | — | — |
| PROK | ProKidney Corp. | F- | 100,6M US$ | 1,64 US$ | — | 818K US$ | -10.288,4 % |
| NTRB | NUTRIBAND INC. | F- | 98,8M US$ | 8,13 US$ | — | 1,6M US$ | -430,4 % |
| ANIX | ANIXA BIOSCIENCES, INC. | sin calificar | 98,7M US$ | 2,84 US$ | — | — | — |
| FTH | Faeth Therapeutics, Inc. | sin calificar | 97,9M US$ | 28,11 US$ | — | — | — |
| PMN | PROMIS NEUROSCIENCES INC. | sin calificar | 97,3M US$ | 10,85 US$ | — | — | — |
| NRXS | NEURAXIS, INC. | D- | 96,7M US$ | 7,70 US$ | — | 5,3M US$ | -144,4 % |
| PYPD | PolyPid Ltd | sin calificar | 95,4M US$ | 5,24 US$ | 2,51 | — | — |
| MNOV | MEDICINOVA, INC. | C- | 93,8M US$ | 1,91 US$ | — | 920,5K US$ | -1168,2 % |
| BMEA | Biomea Fusion, Inc. | sin calificar | 91,7M US$ | 1,27 US$ | — | — | — |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | 91,4M US$ | 1,18 US$ | — | 508K US$ | -7884,1 % |
| CGTX | Cognition Therapeutics, Inc. | sin calificar | 90,5M US$ | 0,95 US$ | — | — | — |
| RLYB | RALLYBIO CORPORATION | D | 89,5M US$ | 16,86 US$ | 3,43 | 646K US$ | 7051,2 % |
| ICCC | ImmuCell Corporation | A | 89,3M US$ | 9,83 US$ | 140,43 | 30,7M US$ | 2,6 % |
| ACRV | Acrivon Therapeutics, Inc. | sin calificar | 89,1M US$ | 2,08 US$ | — | — | — |
| ONCY | ONCOLYTICS BIOTECH INC. | sin calificar | 85,2M US$ | 0,67 US$ | — | — | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | 84,8M US$ | 3,27 US$ | — | 40K US$ | -118.029,5 % |
| GUTS | Fractyl Health, Inc. | F- | 82,7M US$ | 0,52 US$ | — | 0,00 US$ | — |
| PTHS | Pelthos Therapeutics Inc. | C- | 81,5M US$ | 21,29 US$ | — | 50,4M US$ | -171,4 % |
| FBIO | Fortress Biotech, Inc. | B | 81,4M US$ | 2,20 US$ | 0,83 | 68,5M US$ | 163,3 % |
| TELO | Telomir Pharmaceuticals, Inc. | sin calificar | 81,2M US$ | 1,18 US$ | — | — | — |
| ATRA | ATARA BIOTHERAPEUTICS, INC. | D | 81,1M US$ | 8,08 US$ | — | 6,2M US$ | -269,4 % |
| ALDX | ALDEYRA THERAPEUTICS, INC. | sin calificar | 79,6M US$ | 1,32 US$ | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | C- | 77,3M US$ | 4,50 US$ | — | 30,3M US$ | -102,8 % |
| PMVP | PMV PHARMACEUTICALS, INC. | sin calificar | 77M US$ | 1,44 US$ | — | — | — |
| ATTO | Attovia Therapeutics, Inc. | sin calificar | 76M US$ | 18,12 US$ | — | — | — |
| IBIO | IBIO, INC. | D- | 75,6M US$ | 1,18 US$ | — | 100K US$ | -33.044,0 % |
| LONA | LeonaBio, Inc. | sin calificar | 75,5M US$ | 3,53 US$ | — | — | — |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | 74,9M US$ | 3,02 US$ | — | 194K US$ | -3985,6 % |
| OSTX | OS THERAPIES INCORPORATED | sin calificar | 74,3M US$ | 1,61 US$ | — | — | — |
| GANX | GAIN THERAPEUTICS, INC | sin calificar | 73,8M US$ | 1,69 US$ | — | — | — |
| CING | Cingulate Inc. | sin calificar | 71,7M US$ | 4,93 US$ | — | — | — |
| OKYO | OKYO Pharma Limited | sin calificar | 71,4M US$ | 1,36 US$ | — | — | — |
| RNXT | RENOVORX, INC. | D- | 70,6M US$ | 1,57 US$ | — | 2M US$ | -621,7 % |
| MAIA | MAIA Biotechnology, Inc. | F | 69,9M US$ | 1,15 US$ | — | 0,00 US$ | — |
| SPRO | Spero Therapeutics, Inc. | C | 69,9M US$ | 1,20 US$ | 8,57 | 47M US$ | 15,7 % |
| BSEM | BioStem Technologies, Inc. | D- | 69,2M US$ | 3,88 US$ | — | 34,6M US$ | -81,8 % |
| TENX | TENAX THERAPEUTICS, INC. | F | 69M US$ | 1,85 US$ | — | 0,00 US$ | — |
| KLRS | KALARIS THERAPEUTICS, INC. | sin calificar | 69M US$ | 2,90 US$ | — | — | — |
| RNTX | Rein Therapeutics, Inc. | F | 68,5M US$ | 0,79 US$ | — | 0,00 US$ | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | 68,2M US$ | 4,90 US$ | — | 60,7M US$ | -1,8 % |
| PLRX | PLIANT THERAPEUTICS, INC. | D | 66,9M US$ | 1,08 US$ | — | 0,00 US$ | — |
| XBIT | XBIOTECH INC. | sin calificar | 66,5M US$ | 2,18 US$ | — | — | — |
| ALPS | ALPS GROUP INC | sin calificar | 65,7M US$ | 0,40 US$ | — | — | — |
| HYFT | MindWalk Holdings Corp. | C- | 64,7M US$ | 1,39 US$ | — | 19,8M US$ | -43,6 % |
| LNAI | Lunai Bioworks Inc. | sin calificar | 64,2M US$ | 1,77 US$ | — | — | — |
| ACET | Adicet Bio, Inc. | sin calificar | 63,9M US$ | 6,83 US$ | — | — | — |
| CNTB | Connect Biopharma Holdings Limited | C- | 63M US$ | 1,00 US$ | — | 3M US$ | -2336,3 % |
| INKT | MiNK Therapeutics, Inc. | sin calificar | 62,3M US$ | 12,20 US$ | — | — | — |
| HYPD | HYPERION DEFI, INC. | D+ | 62,1M US$ | 4,00 US$ | — | 1,4M US$ | 474,9 % |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | 61,4M US$ | 15,21 US$ | — | 0,00 US$ | — |
| MREO | MEREO BIOPHARMA GROUP PLC | B | 59,5M US$ | 0,37 US$ | — | 500K US$ | -5619,8 % |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | 59,4M US$ | 2,33 US$ | — | 357,9K US$ | -3089,6 % |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | C- | 58,6M US$ | 0,31 US$ | — | 151,2M US$ | -22,5 % |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | 58,4M US$ | 0,63 US$ | — | -1,2M US$ | 5253,5 % |
| BOLD | BOUNDLESS BIO, INC. | sin calificar | 58,2M US$ | 2,56 US$ | — | — | — |
| EXOZ | EXOZYMES INC. | sin calificar | 58M US$ | 6,25 US$ | — | — | — |
| ALGS | Aligos Therapeutics, Inc. | D- | 57,7M US$ | 5,54 US$ | — | 3,7M US$ | -2031,1 % |
| BLSM | BlossomHill Therapeutics, Inc. | sin calificar | 56,9M US$ | 21,48 US$ | — | — | — |
| SCTX | SCRIBE THERAPEUTICS INC. | sin calificar | 56,8M US$ | 23,01 US$ | — | — | — |
| SKYE | Skye Bioscience, Inc. | sin calificar | 56,3M US$ | 1,59 US$ | — | — | — |
| BCAB | BIOATLA, INC. | sin calificar | 56,1M US$ | 1,74 US$ | — | — | — |
| ANVS | Annovis Bio, Inc. | F | 55,8M US$ | 1,31 US$ | — | 0,00 US$ | — |
| INMB | INMUNE BIO INC. | D- | 54,4M US$ | 1,96 US$ | — | 50K US$ | -36.832,0 % |
| XLO | Xilio Therapeutics, Inc. | C- | 53,1M US$ | 9,19 US$ | — | 64,1M US$ | -34,1 % |
| CLNN | Clene Inc. | D | 52,7M US$ | 4,11 US$ | — | 197K US$ | -20.059,9 % |
| IMA | ImageneBio, Inc. | D- | 52,2M US$ | 4,60 US$ | — | 800K US$ | -6560,5 % |
| SER | Serina Therapeutics, Inc. | D | 50,8M US$ | 2,00 US$ | — | 130K US$ | -16.288,5 % |
| CLGN | CollPlant Biotechnologies Ltd | B- | 50,2M US$ | 3,92 US$ | — | 2,4M US$ | -484,6 % |
| ELTX | Elicio Therapeutics, Inc. | sin calificar | 48,6M US$ | 1,85 US$ | — | — | — |
| TIL | Instil Bio, Inc. | C- | 48,5M US$ | 7,16 US$ | — | 9M US$ | -337,7 % |
| DWTX | Dogwood Therapeutics, Inc. | sin calificar | 45,6M US$ | 1,34 US$ | — | — | — |
| TVGN | Tevogen Inc. | sin calificar | 45,1M US$ | 6,93 US$ | — | — | — |
| FLNA | Filana Therapeutics, Inc. | sin calificar | 44,8M US$ | 0,93 US$ | — | — | — |
| GRCE | Grace Therapeutics, Inc. | sin calificar | 44,8M US$ | 2,13 US$ | — | — | — |
| CELU | Celularity Inc. | C | 44,6M US$ | 1,38 US$ | — | 19M US$ | -374,7 % |
| HOWL | WEREWOLF THERAPEUTICS, INC. | sin calificar | 44M US$ | 0,91 US$ | — | — | — |
| CRVO | CervoMed Inc. | F- | 43,5M US$ | 2,88 US$ | — | 331,3K US$ | -9160,9 % |
| MGX | Metagenomi Therapeutics, Inc. | D- | 42,9M US$ | 1,14 US$ | — | 22,3M US$ | -418,5 % |
| LITS | Lite Strategy, Inc. | D | 41,8M US$ | 1,38 US$ | — | 0,00 US$ | — |
| PDSB | PDS Biotechnology Corp | sin calificar | 41,4M US$ | 0,74 US$ | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | 41,2M US$ | 0,32 US$ | — | 7,1M US$ | -1655,4 % |
| KAPA | KAIROS PHARMA, LTD. | sin calificar | 39,8M US$ | 1,68 US$ | — | — | — |
| ATHE | ALTERITY THERAPEUTICS LTD | sin calificar | 38,4M US$ | 3,61 US$ | — | — | — |
| ICU | SeaStar Medical Holding Corp | D- | 36,8M US$ | 3,69 US$ | — | 1,7M US$ | -795,5 % |
| ATNM | ACTINIUM PHARMACEUTICALS, INC. | D+ | 36M US$ | 1,15 US$ | 3,18 | 90K US$ | 12.564,4 % |
| NIKI | Niki BioSolutions, Inc. | sin calificar | 35M US$ | 4,76 US$ | — | — | — |
| MCRB | Seres Therapeutics, Inc. | D- | 34,8M US$ | 3,50 US$ | — | 1,9M US$ | -1192,9 % |
| EDSA | EDESA BIOTECH, INC. | sin calificar | 34,8M US$ | 3,61 US$ | — | — | — |
| NNVC | NANOVIRICIDES, INC. | F | 33,1M US$ | 1,30 US$ | — | 0,00 US$ | — |
| BYSI | BeyondSpring Inc. | D | 31,8M US$ | 0,77 US$ | — | 0,00 US$ | — |
| CVM | CEL-SCI CORPORATION | sin calificar | 31,1M US$ | 1,77 US$ | — | — | — |
| ATYR | aTYR PHARMA INC | F- | 30,2M US$ | 0,31 US$ | — | 190K US$ | -32.003,7 % |
| ELAB | PMGC HOLDINGS INC. | D- | 30M US$ | 3,70 US$ | — | 2,6M US$ | -523,0 % |
| CNTX | CONTEXT THERAPEUTICS INC. | sin calificar | 29,2M US$ | 0,32 US$ | — | — | — |
| IGC | IGC PHARMA, INC. | C- | 28M US$ | 0,27 US$ | — | 1,3M US$ | -560,3 % |
| ABVC | ABVC BioPharma, Inc. | D- | 28M US$ | 1,05 US$ | — | 296K US$ | -2400,9 % |
| KYNB | KYNTRA BIO, INC. | F | 27,7M US$ | 6,84 US$ | 0,15 | 4,6M US$ | 3967,8 % |
| EVAX | Evaxion A/S | B- | 27,3M US$ | 3,27 US$ | — | 7,5M US$ | -102,4 % |
| CALC | CalciMedica, Inc. | sin calificar | 26,3M US$ | 1,60 US$ | — | — | — |
| APRE | Aprea Therapeutics, Inc. | sin calificar | 26M US$ | 0,76 US$ | — | — | — |
| APLM | Apollomics Inc. | B | 25,8M US$ | 23,40 US$ | — | 8,5M US$ | -128,7 % |
| NRXP | NRX Pharmaceuticals, Inc. | B | 25,8M US$ | 2,92 US$ | — | 3,4M US$ | -691,8 % |
| ENLV | Enlivex Ltd. | sin calificar | 23,7M US$ | 0,49 US$ | 0,02 | — | — |
| GRDX | GRIDAI TECHNOLOGIES CORP | F- | 23,5M US$ | 3,30 US$ | — | 36,3K US$ | -56.864,0 % |
| NXTC | NEXTCURE, INC | sin calificar | 22,4M US$ | 4,90 US$ | — | — | — |
| COCP | COCRYSTAL PHARMA, INC. | sin calificar | 21,8M US$ | 1,13 US$ | — | — | — |
| YARW | YARROW BIOSCIENCE, INC. | C- | 20,6M US$ | 23,97 US$ | — | 570K US$ | -4646,1 % |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | sin calificar | 20M US$ | 0,46 US$ | — | — | — |
| JSPR | JASPER THERAPEUTICS, INC. | sin calificar | 19,8M US$ | 0,60 US$ | — | — | — |
| ATOS | ATOSSA THERAPEUTICS, INC. | sin calificar | 19,7M US$ | 1,97 US$ | — | — | — |
| CNSP | CNS Pharmaceuticals, Inc. | sin calificar | 18,6M US$ | 4,93 US$ | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | 18,3M US$ | 1,10 US$ | — | 3,9M US$ | -220,5 % |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | sin calificar | 18,1M US$ | 2,82 US$ | — | — | — |
| LPCN | LIPOCINE INC. | C- | 17,7M US$ | 2,15 US$ | — | 1,6M US$ | -755,1 % |
| ACTU | Actuate Therapeutics, Inc. | sin calificar | 17,2M US$ | 0,72 US$ | — | — | — |
| TVRD | TVARDI THERAPEUTICS, INC. | C- | 17,2M US$ | 1,29 US$ | — | 7,6M US$ | -344,2 % |
| CLRB | Cellectar Biosciences, Inc. | sin calificar | 17,2M US$ | 1,82 US$ | — | — | — |
| DYAI | DYADIC INTERNATIONAL INC | F- | 17,1M US$ | 0,47 US$ | — | 3,8M US$ | -200,5 % |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | 16,7M US$ | 9,38 US$ | — | 13,2M US$ | -63,6 % |
| LTGO | Latigo Biotherapeutics, Inc. | sin calificar | 16,7M US$ | 18,10 US$ | — | — | — |
| KTTA | PASITHEA THERAPEUTICS CORP. | sin calificar | 16,4M US$ | 0,49 US$ | — | — | — |
| BCTX | BRIACELL THERAPEUTICS CORP. | sin calificar | 16,1M US$ | 4,08 US$ | — | — | — |
| KZIA | Kazia Therapeutics Limited. | F | 15,8M US$ | 9,78 US$ | 8,68 | 29,3K US$ | -54.287,3 % |
| BCDA | BioCardia, Inc. | F | 15,6M US$ | 1,03 US$ | — | 0,00 US$ | — |
| CTXR | Citius Pharmaceuticals, Inc. | sin calificar | 15,3M US$ | 0,56 US$ | — | — | — |
| PASG | PASSAGE BIO, INC. | sin calificar | 15M US$ | 4,67 US$ | — | — | — |
| CNSY | CERENOME, INC. | F- | 14,1M US$ | 1,86 US$ | — | 4,2M US$ | -620,7 % |
| HIND | VYOME HOLDINGS, INC. | F- | 14,1M US$ | 2,01 US$ | — | 129,7K US$ | -8716,8 % |
| LTRN | Lantern Pharma Inc. | sin calificar | 13,9M US$ | 1,09 US$ | — | — | — |
| NCEL | NewcelX Ltd. | sin calificar | 13,7M US$ | 2,87 US$ | 1,33 | — | — |
| LSTA | LISATA THERAPEUTICS, INC. | C- | 13,1M US$ | 1,46 US$ | — | 100K US$ | -14.621,0 % |
| AEON | AEON Biopharma, Inc. | sin calificar | 13,1M US$ | 0,26 US$ | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | 13M US$ | 0,29 US$ | — | 2,5M US$ | -2702,6 % |
| PLUR | Pluri Inc. | D | 12,8M US$ | 1,04 US$ | — | 1M US$ | -2344,6 % |
| INAB | IN8BIO, INC. | sin calificar | 12,8M US$ | 1,30 US$ | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | 12,5M US$ | 0,81 US$ | — | 1,4M US$ | -804,4 % |
| RADX | Radiopharm Theranostics Limited | F- | 12,2M US$ | 1,55 US$ | — | 3,6M US$ | -1055,3 % |
| TPST | Tempest Therapeutics, Inc. | sin calificar | 12,1M US$ | 0,82 US$ | — | — | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | 11,8M US$ | 2,67 US$ | — | 0,00 US$ | — |
| BIVI | BioVie Inc. | sin calificar | 11,6M US$ | 1,54 US$ | — | — | — |
| CMMB | SNOWDRIFT PARENT CORPORATION | sin calificar | 11,6M US$ | 1,61 US$ | 89,44 | — | — |
| BLRX | BioLineRx Ltd | C- | 11,3M US$ | 2,60 US$ | — | 1,2M US$ | -171,7 % |
| INTS | INTENSITY THERAPEUTICS, INC. | sin calificar | 11,2M US$ | 3,43 US$ | — | — | — |
| MTVA | METAVIA INC. | sin calificar | 11M US$ | 1,67 US$ | — | — | — |
| ADIL | Adial Pharmaceuticals, Inc. | sin calificar | 10,7M US$ | 4,09 US$ | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | 10,4M US$ | 0,53 US$ | — | 0,00 US$ | — |
| KALA | KALA BIO, INC. | F | 9,8M US$ | 0,51 US$ | — | 0,00 US$ | — |
| TOVX | Theriva Biologics, Inc. | sin calificar | 9,8M US$ | 0,21 US$ | — | — | — |
| GDTC | CytoMed Therapeutics Limited | D- | 9,8M US$ | 0,83 US$ | — | 253,9K US$ | -1227,1 % |
| TRAW | Traws Pharma, Inc. | C- | 9,6M US$ | 0,62 US$ | — | 2,8M US$ | -773,0 % |
| SNTI | Senti Biosciences Holdings, Inc. | F- | 9,5M US$ | 0,31 US$ | — | 22K US$ | -225.290,9 % |
| IMRN | IMMURON LIMITED | D- | 9,5M US$ | 1,18 US$ | — | 5,1M US$ | -71,6 % |
| FBLG | FibroBiologics, Inc. | sin calificar | 8,9M US$ | 1,33 US$ | — | — | — |
| ALZN | ALZAMEND NEURO, INC. | sin calificar | 8,8M US$ | 1,83 US$ | — | — | — |
| VRAX | Virax Biolabs Group Ltd | C- | 8,2M US$ | 2,20 US$ | — | 6,3K US$ | -95.739,2 % |
| ENSC | ENSYSCE BIOSCIENCES, INC. | D- | 8,2M US$ | 0,42 US$ | — | 4,5M US$ | -280,5 % |
| SNGX | SOLIGENIX, INC. | D- | 7,8M US$ | 0,36 US$ | — | 119,4K US$ | -8577,8 % |
| CBUS | Cibus, Inc. | C- | 7,8M US$ | 1,56 US$ | — | 4,3M US$ | -2258,9 % |
| XCUR | EXICURE, INC. | F | 7,5M US$ | 1,14 US$ | — | 0,00 US$ | — |
| IMNN | Imunon, Inc. | sin calificar | 7,4M US$ | 1,32 US$ | — | — | — |
| ALLR | Allarity Therapeutics, Inc. | B- | 7,4M US$ | 0,97 US$ | — | 320K US$ | -3854,4 % |
| ARTL | ARTELO BIOSCIENCES, INC. | sin calificar | 7,2M US$ | 4,15 US$ | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | D- | 6,9M US$ | 3,58 US$ | — | 4,7M US$ | -611,5 % |
| ACXP | Acurx Pharmaceuticals, Inc. | sin calificar | 6,9M US$ | 1,31 US$ | — | — | — |
| ENVB | ENVERIC BIOSCIENCES, INC. | sin calificar | 6,6M US$ | 1,47 US$ | — | — | — |
| CELZ | Creative Medical Technology Holdings, Inc. | D- | 6,2M US$ | 0,95 US$ | — | 3K US$ | -201.355,4 % |
| PULM | PULMATRIX, INC. | B- | 5,9M US$ | 1,61 US$ | — | 7,8M US$ | -51,4 % |
| AGMB | AgomAb Therapeutics NV | sin calificar | 5,7M US$ | 10,46 US$ | — | — | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | C- | 5,6M US$ | 1,90 US$ | — | 14,5K US$ | -44.771,8 % |
| XBIO | XENETIC BIOSCIENCES, INC. | D- | 5,4M US$ | 2,30 US$ | — | 3,3M US$ | -75,9 % |
| ERNA | Ernexa Therapeutics Inc. | B- | 5,3M US$ | 3,23 US$ | — | 582K US$ | -2106,0 % |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | 5,2M US$ | 2,20 US$ | — | 451K US$ | -1545,2 % |
| PCSA | Processa Pharmaceuticals, Inc. | sin calificar | 4,9M US$ | 1,76 US$ | — | — | — |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | 4,8M US$ | 1,39 US$ | — | 1,5M US$ | -558,6 % |
| PHIO | PHIO PHARMACEUTICALS CORP. | sin calificar | 4,7M US$ | 1,03 US$ | — | — | — |
| GRI | GRI BIO, INC. | sin calificar | 4,5M US$ | 2,07 US$ | — | — | — |
| PMCB | PHARMACYTE BIOTECH, INC. | D | 4,5M US$ | 0,42 US$ | — | 0,00 US$ | — |
| DRMA | DERMATA THERAPEUTICS, INC. | sin calificar | 4,5M US$ | 1,12 US$ | — | — | — |
| QNTM | Quantum BioPharma Ltd. | sin calificar | 4,3M US$ | 3,80 US$ | — | — | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | 4,3M US$ | 1,21 US$ | — | 1,1M US$ | -729,9 % |
| OSRH | OSR HEALTH, INC. | D- | 4,1M US$ | 0,12 US$ | — | 1,8M US$ | -824,4 % |
| CVKD | Cadrenal Therapeutics, Inc. | sin calificar | 3,9M US$ | 1,09 US$ | — | — | — |
| EVGN | EVOGENE LTD. | D- | 3,5M US$ | 0,41 US$ | — | 1,3M US$ | -649,2 % |
| ADXN | Addex Therapeutics Ltd | D- | 3,5M US$ | 2,81 US$ | — | 36K US$ | -22.448,4 % |
| REVB | REVELATION BIOSCIENCES, INC. | sin calificar | 3,3M US$ | 0,84 US$ | — | — | — |
| APVO | Aptevo Therapeutics Inc. | sin calificar | 3,3M US$ | 1,82 US$ | — | — | — |
| HCWB | HCW Biologics Inc. | B- | 3,3M US$ | 1,78 US$ | — | 6,7M US$ | -83,8 % |
| MBIO | MUSTANG BIO, INC. | sin calificar | 3,2M US$ | 0,48 US$ | — | — | — |
| PBM | PSYENCE BIOMEDICAL LTD | sin calificar | 3M US$ | 5,50 US$ | — | — | — |
| HLSQ | BiomX Inc. | sin calificar | 2,8M US$ | 0,43 US$ | — | — | — |
| SILO | SILO PHARMA, INC. | F- | 2,6M US$ | 1,63 US$ | — | 54,1K US$ | -8269,5 % |
| GOVX | GEOVAX LABS, INC. | D | 2,6M US$ | 0,35 US$ | — | 0,00 US$ | — |
| TCRT | Alaunos Therapeutics, Inc. | D- | 2,5M US$ | 0,97 US$ | — | 3K US$ | -133.666,7 % |
| GNPX | Genprex, Inc. | D | 2,4M US$ | 2,89 US$ | — | 0,00 US$ | — |
| AZTR | Azitra, Inc. | F- | 2,3M US$ | 0,13 US$ | — | 0,00 US$ | — |
| VBIO | Valion Bio, Inc. | F- | 2,2M US$ | 2,98 US$ | — | 482K US$ | -3890,0 % |
| OGEN | ORAGENICS, INC. | sin calificar | 2,2M US$ | 0,49 US$ | — | — | — |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | 1,9M US$ | 2,52 US$ | — | 21,8K US$ | -42.206,9 % |
| AIM | AIM IMMUNOTECH INC. | D | 1,9M US$ | 0,17 US$ | — | 95K US$ | -15.021,1 % |
| CANF | Can-Fite BioPharma Ltd. | F- | 1,8M US$ | 2,18 US$ | — | 405K US$ | -2426,7 % |
| SPRC | SCISPARC LTD. | F- | 1,8M US$ | 4,84 US$ | — | 856K US$ | -1422,8 % |
| CRIS | CURIS, INC. | F- | 1,7M US$ | 0,82 US$ | — | 4,3M US$ | -490,3 % |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | sin calificar | 1,6M US$ | 1,67 US$ | — | — | — |
| DCOY | Decoy Therapeutics Inc. | sin calificar | 1,4M US$ | 2,11 US$ | — | — | — |
| BBLG | BONE BIOLOGICS CORPORATION | sin calificar | 1,3M US$ | 0,48 US$ | — | — | — |
| VIVS | VivoSim Labs, Inc. | D | 1,1M US$ | 0,21 US$ | — | 112K US$ | -11.016,1 % |
| CLDI | Calidi Biotherapeutics, Inc. | sin calificar | 1,1M US$ | 1,05 US$ | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | sin calificar | 1M US$ | 0,98 US$ | — | — | — |
| QNRX | Quoin Pharmaceuticals Ltd. | sin calificar | 997,3K US$ | 5,68 US$ | — | — | — |
| ONCO | Onconetix, Inc. | D- | 949K US$ | 0,82 US$ | — | 645,8K US$ | -1578,8 % |
| CMND | Clearmind Medicine Inc. | sin calificar | 920,4K US$ | 0,79 US$ | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | sin calificar | 586,2K US$ | 0,52 US$ | — | — | — |
| KLRA | Kailera Therapeutics, Inc. | sin calificar | 561,9K US$ | 10,99 US$ | — | — | — |
| PLRZ | Polyrizon Ltd. | sin calificar | 488,7K US$ | 10,78 US$ | 2,20 | — | — |
| CDT | CDT EQUITY INC. | sin calificar | 441,2K US$ | 1,45 US$ | — | — | — |
| EDVA | SPLASH BEVERAGE GROUP, INC. | D | 370,9K US$ | 0,17 US$ | — | 32,1K US$ | -53.856,5 % |
| BDRX | Biodexa Pharmaceuticals PLC | sin calificar | 369,2K US$ | 0,67 US$ | — | — | — |
| SLXN | SILEXION THERAPEUTICS CORP | sin calificar | 162,5K US$ | 0,32 US$ | — | — | — |
| NEUP | Neuphoria Therapeutics Inc. | F- | 108,2K US$ | 3,60 US$ | — | 1,2M US$ | -1145,7 % |
| KPTI | Karyopharm Therapeutics Inc. | B | 30,7K US$ | 1,21 US$ | — | 146,6M US$ | -153,3 % |
| PPBT | PURPLE BIOTECH LTD. | sin calificar | 362,44 US$ | 1,51 US$ | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | sin calificar | — | 20,64 US$ | — | — | — |
| APGE | Apogee Therapeutics, Inc. | sin calificar | — | 135,07 US$ | — | — | — |
| ATAI | AtaiBeckley Inc. | sin calificar | — | 7,35 US$ | — | 4,1M US$ | -16.142,0 % |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | 0,74 US$ | — | 0,00 US$ | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | 84,95 US$ | — | 42,2M US$ | -1189,9 % |
| ETRA | Electra Therapeutics, Inc. | sin calificar | — | 11,35 US$ | — | — | — |
| FBRX | FORTE BIOSCIENCES, INC. | sin calificar | — | 76,99 US$ | — | — | — |
| SLBT | SL Science Holding Limited | sin calificar | — | 1,83 US$ | — | — | — |
| VCRE | Vicore Pharma Holding AB | sin calificar | — | 9,53 US$ | — | — | — |
| VRXA | Veraxa Biotech Holding AG | sin calificar | — | 1,32 US$ | — | — | — |
| VTVT | vTv Therapeutics Inc. | D- | — | 30,01 US$ | — | 36,8M US$ | -12,9 % |
Fundamentales de informes ante la SEC, precios de la última pasada de datos de mercado. Ordena por cualquier columna; las empresas sin cifra van al final en ambos sentidos.
Ordenado por capitalización, de mayor a menor; pulsa cualquier columna para reordenar. Las empresas sin cifra van al final en ambos sentidos, porque un PER que falta significa que no hay beneficio y no que esté barata. Nada de esto es una recomendación.